About this Session:
2:10 PM - Hinge Health: Discover how Hinge Health is transforming digital care for musculoskeletal conditions, launching a new specialized clinical pathway and harnessing cutting-edge technology to empower millions to move past pain and embrace a healthier future.
2:20 PM - Noom: GLP-1s hold great promise for the treatment our rising obesity rates, but come with a high cost - and ongoing treatment - unless paired with the right clinical and lifestyle program to control unnecessary costs. Come learn about Noom’s latest commercial offering that pairs psychology with biology to deliver lasting, cost-effective results for employees and members.
2:30 PM - Mass General Brigham: The Future of Clinical Trials Starts Today with a New Initiative at Mass General Brigham.
2:40 PM - Flow Neuroscience: Flow Neuroscience will share the results of their FDA pivotal trial, unveiling a new paradigm for the treatment of depression and the first at-home alternative to antidepressants in 35 years.